Early drivers of gastric cancer

August 9, 2017 by Leigh Macmillan, Vanderbilt University

Gastric cancer – a leading cause of cancer-related deaths worldwide – is commonly diagnosed at a late stage when most patients have a poor prognosis.

Wael El-Rifai, M.D., Ph.D., and colleagues are exploring the molecular alterations that drive gastric carcinogenesis, to improve early detection, treatment and prevention. They previously showed that knocking out (eliminating) the gene Tff1 in mice induces that include low- and high-grade dysplasia and adenocarcinomas.

Now, they have investigated in low-grade dysplastic lesions and normal stomach tissue from mice and in gastric cancer and normal stomach tissue from humans. Using bioinformatics approaches, they identified transcription (gene expression) networks that were consistently deregulated in both mouse and human lesions.

The findings, reported in the July issue of Genes, Chromosomes and Cancer, suggest that activation of MYC, STAT3, and beta-catenin transcription networks could be an early molecular step in gastric tumorigenesis. The findings also support using the Tff1-knockout mouse model for in vivo studies of molecular mechanisms in .

Explore further: First roadmap of stomach cancer super-enhancers paves the way for new treatments

More information: Zheng Chen et al. Integrated expression analysis identifies transcription networks in mouse and human gastric neoplasia, Genes, Chromosomes and Cancer (2017). DOI: 10.1002/gcc.22456

Related Stories

First roadmap of stomach cancer super-enhancers paves the way for new treatments

July 26, 2017
A*STAR researchers have homed in on a potential new way to diagnose and treat stomach cancer, through the mapping of an unprecedented catalog of almost 3,800 super-enhancers from stomach cancer tumor cells.

Differences in subtypes of gastric cancer may determine prognosis and response to treatment

July 26, 2017
Molecular classification of the four distinct subtypes of gastric cancer could potentially shape tailored treatment options by helping to predict survival outcomes and patients' response to chemotherapy.

Role of innervation explored in gastric tumorigenesis

August 21, 2014
(HealthDay)—Vagal innervation is involved in gastric tumorigenesis, according to an experimental study published in the Aug. 20 issue of Science Translational Medicine.

miR-7 suppresses stomach cancer

August 10, 2015
A study in The Journal of Cell Biology reveals that the microRNA miR-7 suppresses gastric (stomach) cancer by inhibiting a key signaling pathway, and that this protective mechanism is compromised by the cancer-causing bacterium ...

Ironing out the link between H. pylori infection and gastric cancer

December 21, 2012
H. pylori frequently causes gastric ulcers and is also one of the greatest risk factors for gastric cancer. H. pylori infection is also associated with another gastric cancer risk factor, iron deficiency.

Recommended for you

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

February 15, 2018
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...

Team paves the way to the use of immunotherapy to treat aggressive colon tumors

February 15, 2018
In a short space of time, immunotherapy against cancer cells has become a powerful approach to treat cancers such as melanoma and lung cancer. However, to date, most colon tumours appeared to be unresponsive to this kind ...

Can our genes help predict how women respond to ovarian cancer treatment?

February 15, 2018
Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

First comparison of common breast cancer tests finds varied accuracy of predictions

February 15, 2018
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.

Catching up to brain cancer: Researchers develop accurate model of how aggressive cancer cells move and spread

February 15, 2018
A brief chat at a Faculty Senate meeting put two University of Delaware researchers onto an idea that could be of great value to cancer researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.